Breast cancer screening in the UK: does it work?

EBCC 2014 key messages to doctors

Biomarker development for ipilimumab and prostate GVAX treatment

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

PSA as a marker of disease in patients with prostate cancer and bone metastases

ecancermedicalscience Editor's Choice for January 2014

MET variant as a prognostic marker in clear cell renal cell carcinoma

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Understanding the biology of the disease to guide treatment choices

Drop in breast cancer mortality in developed countries varies

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Where to next for the elderly with acute myeloid leukaemia?